Ingevity Corp NGVT
NYSE · XNYS · stock · Chemicals & Allied Products · website · IPO 2016-05-02
Chart by TradingView
6/9
Piotroski F — financial health
2.97
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $1.2B | $1.2B | $1.2B | $1.7B | $1.4B |
| Gross profit | $461.5M | $464.8M | $445.0M | $570.1M | $512.8M |
| Operating income | $418.7M | $425.9M | $423.2M | $452.6M | $422.2M |
| Net income | -$167.1M | -$430.3M | -$5.4M | $211.6M | $118.1M |
| Operating cash flow | $331.2M | $128.6M | $205.1M | $313.4M | $293.3M |
| Total assets | $1.7B | $2.0B | $2.6B | $2.7B | $2.5B |
| Total liabilities | $1.6B | $1.8B | $2.0B | $2.0B | $1.8B |
| Shareholders' equity | $29.7M | $195.2M | $631.4M | $698.3M | $673.8M |
| Ratios | |||||
| Gross margin | 39.5% | 38.7% | 36.6% | 34.2% | 36.9% |
| Operating margin | 35.9% | 35.5% | 34.8% | 27.1% | 30.3% |
| Net margin | -14.3% | -35.9% | -0.4% | 12.7% | 8.5% |
| Return on assets | -10.1% | -21.3% | -0.2% | 7.7% | 4.8% |
| Return on equity | -562.6% | -220.4% | -0.9% | 30.3% | 17.5% |
| Current ratio | 1.33 | 1.87 | 1.81 | 2.25 | 2.70 |
| Revenue growth | -2.7% | -1.3% | -27.1% | 19.9% | 14.4% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 122,000 | $8.7M |
| Point72 Asset Management, L.P. | 68,226 | $4.9M |
| Bridgewater Associates, LP | 17,366 | $1.2M |
Why these scores methodology →
Piotroski F-score: 6/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 2.97 (safe)
- Working capital / assets 0.068
- Retained earnings / assets 0.245
- EBIT / assets 0.254
- Equity / liabilities 0.018
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001653477 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.